Current management of corticosteroid-induced osteoporosis: Variations in awareness and management

Irish Journal of Medical Science

Volumn 173, Issue 1, 2004, Pages 20-22

  Ryan, J G ^a   Morgan, R K ^a   Lavin, P J ^a   Murray, F E ^a   O'Connell, Paul G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTON PUMP INHIBITOR; RALOXIFENE; SUCRALFATE;

ADULT; ARTHRITIS; ARTICLE; ASTHMA; AUTOIMMUNE HEPATITIS; AWARENESS; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DRUG INDICATION; ENTERITIS; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH PROTECTION; VASCULITIS;

EID: 3042581428     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02914518     Document Type: Article

References (18)

1. Tobias JH. Management of steroid-induced osteoporosis: what is the current state of play? Rheumatology (Oxford) 1999; 38 (3): 198-201.
2. Goldstein MH, Fallon JJ, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733-49.
3. Rosen HN, Rosenblatt M. Glucocorticoids and osteoporosis: pathogenesis and clinical features, In UpToDate Rose BD (Ed), UpToDate, Wellesley, MA 2001.
4. Writing group for the Bone and Tooth Society and Royal College of Physicians. Glucocorticoid-induced Osteoporosis: guidelines for the prevention and treatment. London: Royal College of Physicians. December 2002.
5. National Osteoporosis Foundation Physician's guide to prevention and treatment of osteoporosis. November 1998.
6. Lenore, Buckley et al. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis, 2001 Update, American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Arthritis Rheum 2001; 44 (7): 1496-503.
7. Reid DM. Editorial corticosteroid-induced osteoporosis: guidelines for prevention. Are they useful? Br J Rheumatol 1997; 36: 1035-7.
8. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and prevention of secondary osteoporosis: a cross sectional study. BMJ 1996; 313: 344-46.
9. Solomon DH, Katz JN, Jacobs JP et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002; 46 (12): 3136-42.
10. Messer J, Reitman D, Sacks HS et al. Association of adrenocorticosteroid therapy and peptic ulcer disease. N Engl J Med 1983; 309 (1): 21-4.
11. Pecora PG, Kaplan B. Corticosteroids and ulcers: is there an association? Ann Pharmacother 1996; 30(7-8): 870-2.
12. Bell R, Carr A, Thompson P. Managing corticosteroid induced osteoporosis in medical outpatients. J R Coll Physicians Lond, March 1, 1997; 31 (2): 158-61.
13. Van Staa TP. Use of oral corticosteroids in the United Kingdom. Q J Med 93: 105-11.
14. Scott EM, Gaywood I, Scott BB for the British society of gastroenterology. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease Gut 2000; 46(suppl 1): il-i8.
15. Kasiske BT et al. Recommendations for the surveillance of renal transplant recipients. J Am Soc Nephrol 1 LS 2000: 1-86.
16. Gudbjornsson B, Juliusson UI, Gudjonsson FV. Extended report: Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 2002; 61: 32-6.
17. Hart SR, Green B. Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe. Postgrad Med J 2002; 78: 242-43.
18. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial. JAMA 2002; 888: 321-33.